Table 2a:

Diabetes care targets, including cardiovascular risk factor management in participants with prior history of cardiovascular disease at VA sites vs. non-VA sites

	VA	Non VA	p-value	Adj. p-value*
N	127	201
Among participants With CVD history
HbA1c <7% (<53 mmol/mol)	23(18.1%)	22(10.9%)	0.094	0.093
BP <140/90 mmHg	101(80.2%)	141(70.1%)	0.060	0.035
Treated for HTN	119(93.7%)	187(93.0%)	0.993	0.721
LDLc <70 mg/dL (1.8 mmol/L)	61(50.0%)	72(36.9%)	0.029	0.340
LDLc <100 mg/dL (2.6 mmol/L)	99(81.1%)	145(74.4%)	0.208	0.700
On statin	111(87.4%)	169(84.1%)	0.504	0.872
Aspirin	104(81.9%)	154(76.6%)	0.319	0.867

Counts and column percentages of participants with CVD history with key diabetes management treatment goals at VA and non-VA clinical sites.

^*Adjusted for age, race, ethnicity, and sex